Eikon Therapeutics, Inc. Common Stock (EIKN : NASDAQ)
Common Stock
$8.51
USD
+0.00 (%)
Last updated: 2026-09-17
Get EIKN alerts:
EIKN
Eikon Therapeutics, Inc. Common Stock
WealthAwesomePerformance
1 Day
-10.33%
1 Week
-20.69%
1 Month
-18.72%
YTD
-12.54%
Key Statistics
Market Cap
$460.94M
52W High
$17.40
52W Low
$7.90
P/E Ratio
-
50 Day MA
$10.30
200 Day MA
$11.07
Beta
-
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/17/2026 | $8.65 | $9.33 | $8.57 | $8.60 | $8.60 | 640,191 |
| 9/16/2026 | $9.47 | $9.64 | $8.39 | $8.51 | $8.51 | 985,792 |
| 9/15/2026 | $9.33 | $10.24 | $9.07 | $9.49 | $9.49 | 843,449 |
| 9/14/2026 | $8.95 | $9.44 | $8.93 | $9.36 | $9.36 | 713,118 |
| 9/11/2026 | $9.28 | $9.56 | $8.79 | $8.94 | $8.94 | 1,010,238 |
| 9/10/2026 | $10.65 | $10.68 | $9.17 | $9.21 | $9.21 | 665,100 |
| 9/9/2026 | $11.01 | $11.47 | $10.63 | $10.73 | $10.73 | 752,400 |
| 9/8/2026 | $10.81 | $11.03 | $10.61 | $10.71 | $10.71 | 462,300 |
| 9/4/2026 | $10.81 | $11.05 | $10.62 | $10.86 | $10.86 | 238,700 |
| 9/3/2026 | $11.45 | $11.66 | $10.91 | $10.96 | $10.96 | 384,300 |
Analyst Price Targets
Based on analyst covering EIKN · as of Sep 17, 2026
Wall Street analysts forecast EIKN stock price to rise 189.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
US$24.60
+189.1% Upside
Current Price
US$8.51
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EIKN's historical volatility
30-Day Vol
96.8%
Annualized
90-Day Vol
89.4%
Annualized
Trend (90d)
-42.2%
Annualized drift
90d Mean
US$7.40
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$8.18 | US$5.86 – US$11.42 |
| 60 trading days | US$7.78 | US$4.85 – US$12.47 |
| 90 trading days | US$7.40 | US$4.15 – US$13.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Eikon Therapeutics, Inc. Common Stock
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-317.23M
- Profit Margin
- 0.00%
- ROE (TTM)
- -125.02%
- EPS (Diluted)
- -5.34
- Book Value
- 8.62
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About EIKN.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DLXY | Delixy Holdings Limited Ordinary Shares | $2.29 | +451.81% |
| MEDS | DataMEDS AI, Inc. | $6.07 | +274.69% |
| SNYR | Synergy CHC Corp. Common Stock | $0.27 | +234.15% |
| QCLS | Q/C Technologies, Inc. | $0.96 | +118.45% |
| AEHL | Antelope Enterprise Holdings Ltd | $9.22 | +78.68% |
| ZTG | Zenta Group Company Limited | $1.18 | +75.33% |
| PDSB | PDS Biotechnology Corp | $0.99 | +69.25% |
| TPST | Tempest Therapeutics Inc | $1.21 | +60.18% |